Blood test could spare thousands from harsh chemo, or target it better
NCT ID NCT07340567
Summary
This large international trial aims to personalize chemotherapy for patients with stage III colon cancer. After surgery, a blood test looks for tiny traces of leftover cancer. Patients with a negative test may get a shorter, gentler chemo regimen, while those with a positive test may get a stronger one. The goal is to better match treatment intensity to each person's risk of the cancer returning.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Institut Gustave Roussy
Villejuif, 94800, France
Contact Email: •••••@•••••
-
Onkologikliniken
Uppsala, 75185, Sweden
Contact Email: •••••@•••••
-
Sahlgrenska University Hospital
Gothenburg, 41345, Sweden
Contact Email: •••••@•••••
-
Skäne University Hospital
Lund, 22185, Sweden
Contact Email: •••••@•••••
-
Södersjukhuset
Stockholm, 11883, Sweden
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.